EKATERINA TAYLOR: Open Payments
NPI 1093580581 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 12 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,827 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $258 |
| Novocure Inc. | 1 | $145 |
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
| Blueprint Medicines Corporation | 1 | $114 |
| PFIZER INC. | 1 | $108 |
| Aveo Pharmaceuticals, Inc. | 1 | $106 |
| PharmaEssentia USA Corporation | 1 | $66 |
| Celgene Corporation | 1 | $23 |
| Incyte Corporation | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
Products named: RYBREVANT, Optune Lua (NovoTTF-200T), OPDIVO, AYVAKIT, PADCEV, FOTIVDA, BESREMI, JAKAFI.
Industry payments across ID — which companies pay providers there.
